Trial intelligence / Profile preview

IV sodium valproate versus IV acetaminophen for acute headache attacks

IRCT20141209020258N102Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in migraine comparing Intravenous sodium valproate with Intravenous acetaminophen (2 arms). Primary endpoint: Pain. Started Jan 2019; status: completed.

02

Drugs

valproic acidacetaminophen
03

Conditions

migraine

Beyond the preview

Go deeper on IRCT20141209020258N102.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141209020258N102.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call